Provided by Tiger Fintech (Singapore) Pte. Ltd.

ENDRA Life Sciences Inc

3.45
-0.2200-5.99%
Volume:145.66K
Turnover:510.51K
Market Cap:1.94M
PE:-0.06
High:3.78
Open:3.37
Low:3.29
Close:3.67
Loading ...

ENDRA Life Sciences Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Yesterday

U.S. RESEARCH ROUNDUP-Lowe's, Netflix, Vulcan Materials

Reuters
·
Yesterday

ENDRA Life Sciences Inc : Ascendiant Capital Markets Cuts Target Price to $50 From $75

THOMSON REUTERS
·
Yesterday

Top broker says Mesoblast shares can rocket 100%

MotleyFool
·
08 Apr

ENDRA Life Sciences FY 2024 GAAP EPS $(56.94) Misses $(47.46) Estimate

Benzinga
·
31 Mar

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging Glp-1 Therapies

THOMSON REUTERS
·
31 Mar

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

Business Wire
·
31 Mar

ENDRA Life Sciences Inc - Q4 Net Loss 2024 $4.2 Mln

THOMSON REUTERS
·
31 Mar

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

THOMSON REUTERS
·
31 Mar

Press Release: ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

Dow Jones
·
31 Mar

Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil

TIPRANKS
·
31 Mar

First Three Children to Commence Treatment With Ryoncil®

GlobeNewswire
·
31 Mar

ENDRA Life Sciences Inc expected to post a loss of $4.10 a share - Earnings Preview

Reuters
·
24 Mar

What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock

Zacks
·
29 Jan

ENDRA Life Sciences Inc trading resumes

TIPRANKS
·
30 Nov 2024

ENDRA Life Sciences Inc trading halted, volatility trading pause

TIPRANKS
·
30 Nov 2024

BRIEF-Endra Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement

Reuters
·
22 Nov 2024

Endra Life Sciences regains compliance with Nasdaq

TIPRANKS
·
22 Nov 2024

ENDRA Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
22 Nov 2024

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Business Wire
·
22 Nov 2024